A Framework to Overcome Challenges in the Management of Infections in Patients with Systemic Lupus Erythematosus

References

• Arnaud L, Tektonidou MG. Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors. Rheumatology. 2020;59(Suppl Supplement_5):v29–v38. PMID: 33280012; PMCID: PMC7719040. doi:10.1093/rheumatology/keaa382
   PubMedGoogle Scholar
• Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am. 1998;24(2):423–456. PMID: 9606766. doi:10.1016/s0889-857x(05)70016-8
   PubMed Web of Science ®Google Scholar
• Barber MRW, Drenkard C, Falasinnu T, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(9):515–532. PMID: 34345022; PMCID: PMC8982275. doi:10.1038/s41584-021-00668-1
   PubMed Web of Science ®Google Scholar
• Barber MRW, Clarke AE. Systemic lupus erythematosus and risk of infection. Expert Rev Clin Immunol. 2020;16(5):527–538. PMID: 32478627. doi:10.1080/1744666X.2020.1763793
   PubMed Web of Science ®Google Scholar
• Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–745. PMID: 30926722. doi:10.1136/annrheumdis-2019-215089
   PubMed Web of Science ®Google Scholar
• Pego-Reigosa JM, Nicholson L, Pooley N, et al. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis. Rheumatology. 2021;60(1):60–72. PMID: 33099651; PMCID: PMC7785308. doi:10.1093/rheumatology/keaa478
   PubMed Web of Science ®Google Scholar
• Danza A, Ruiz-Irastorza G. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus. 2013;22(12):1286–1294. PMID: 24098001. doi:10.1177/0961203313493032
   PubMed Web of Science ®Google Scholar
• Winebrake J, Khalili L, Weiner J, Gartshteyn Y, Park L, Askanase AD. Rheumatologists’ perspective on hydroxychloroquine guidelines. Lupus Sci Med. 2020;7(1):e000427. PMID: 33148665; PMCID: PMC7640534. doi:10.1136/lupus-2020-000427
   PubMed Web of Science ®Google Scholar
• Loza E, Carmona L, Woolf A, et al. Implementation of recommendations in rheumatic and musculoskeletal diseases: considerations for development and uptake. Ann Rheum Dis. 2022;81(10):1344.
   PubMed Web of Science ®Google Scholar
• Teh CL, Wan SA, Ling GR. Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality. Clin Rheumatol. 2018;37(8):2081–2086. PMID: 29667100. doi:10.1007/s10067-018-4102-6
   PubMed Web of Science ®Google Scholar
• Kedves M, Kósa F, Kunovszki P, et al. Large-scale mortality gap between SLE and control population is associated with increased infection-related mortality in lupus. Rheumatology. 2020;59(11):3443–3451. PMID: 32357240; PMCID: PMC7590419. doi:10.1093/rheumatology/keaa188
   PubMed Web of Science ®Google Scholar
• Devlin A, Shmerling RH. Systemic lupus erythematosus and infections. In: Systemic Lupus Erythematosus. Academic Press; 2021:451–459.
   Google Scholar
• Wu X-Y, Yang M, Xie Y-S, et al. Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort. Clin Rheumatol. 2019;38(1):107–115. PMID: 30123930. doi:10.1007/s10067-018-4259-z
   PubMed Web of Science ®Google Scholar
• Walunas TL, Jackson KL, Chung AH, et al. Disease outcomes and care fragmentation among patients with systemic lupus erythematosus. Arthritis Care Res. 2017;69(9):1369–1376. PMID: 27899012; PMCID: PMC5447502. doi:10.1002/acr.23161
   Web of Science ®Google Scholar
• Feldman CH, Marty FM, Winkelmayer WC, et al. Comparative rates of serious infections among patients with systemic lupus erythematosus receiving immunosuppressive medications. Arthritis Rheumatol. 2017;69(2):387–397. PMID: 27589220; PMCID: PMC5274610. doi:10.1002/art.39849
   PubMed Web of Science ®Google Scholar
• Yu Y, Shen H, Zhu C, Guo R, Gao Y, Lu L. Infections caused by extended-spectrum β-lactamase producing Escherichia Coli in systemic lupus erythematosus patients: prevalence, risk factors, and predictive model. Biomed Res Int. 2018;2018:8296720. PMID: 30581868; PMCID: PMC6276506. doi:10.1155/2018/8296720
   PubMed Web of Science ®Google Scholar
• Luijten RK, Cuppen BV, Bijlsma JW, Derksen RH. Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections. Lupus. 2014;23(14):1512–1516. PMID: 25078055. doi:10.1177/0961203314543918
   PubMed Web of Science ®Google Scholar
• Goldblatt F, Yuste J, Isenberg DA, Rahman A, Brown J. Impaired C3b/iC3b deposition on Streptococcus pneumoniae in serum from patients with systemic lupus erythematosus. Rheumatology. 2009;48(12):1498–1501. PMID: 19797312. doi:10.1093/rheumatology/kep289
   PubMed Web of Science ®Google Scholar
• Kogami M, Abe Y, Shimada Y, et al. Bacteremia in systemic lupus erythematosus: risk factors, clinical and microbiological characteristics, and outcomes in the largest single-center retrospective cohort in Japan. Lupus. 2021;30(14):2292–2297. PMID: 34693822. doi:10.1177/09612033211054395
   PubMed Web of Science ®Google Scholar
• Kim SS, Perino G, Boettner F, Miller A, Goodman S. Salmonella septic arthritis of the knees in a patient with systemic lupus erythematosus. Lupus. 2013;22(7):740–743. PMID: 23753601. doi:10.1177/0961203313491022
   PubMed Web of Science ®Google Scholar
• Suárez-Avellaneda A, Quintana JH, Aragón CC, et al. Systemic lupus erythematosus in the intensive care unit: a systematic review. Lupus. 2020;29(11):1364–1376. PMID: 32723062. doi:10.1177/0961203320941941
   PubMed Web of Science ®Google Scholar
• Balbi GGM, Machado-Ribeiro F, Marques CDL, Signorelli F, Levy RA. The interplay between tuberculosis and systemic lupus erythematosus. Curr Opin Rheumatol. 2018;30(4):395–402. PMID: 29438163. doi:10.1097/BOR.0000000000000493
   PubMed Web of Science ®Google Scholar
• Chasset F, Richez C, Martin T, Belot A, Korganow AS, Arnaud L. Rare diseases that mimic Systemic lupus erythematosus (Lupus mimickers). Joint Bone Spine. 2019;86(2):165–171. PMID: 30837156. doi:10.1016/j.jbspin.2018.10.007
   PubMed Web of Science ®Google Scholar
• Machado Ribeiro F, Goldenberg T. Mycobacteria and autoimmunity. Lupus. 2015;24(4–5):374–381. PMID: 25801880. doi:10.1177/0961203314559634
   PubMed Web of Science ®Google Scholar
• Yang SC, Lai YY, Huang MC, Tsai CS, Wang JL. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort. Lupus. 2018;27(11):1819–1827. PMID: 30103646. doi:10.1177/0961203318792352
   PubMed Web of Science ®Google Scholar
• Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V. Viral infections and systemic lupus erythematosus: new players in an old story. Viruses. 2021;13(2):277. PMID: 33670195; PMCID: PMC7916951. doi:10.3390/v13020277
   PubMed Web of Science ®Google Scholar
• Chen D, Li H, Xie J, Zhan Z, Liang L, Yang X. Herpes zoster in patients with systemic lupus erythematosus: clinical features, complications and risk factors. Exp Ther Med. 2017;14(6):6222–6228. doi:10.3892/etm.2017.5297
   PubMed Web of Science ®Google Scholar
• Wang S, Chen Y, Xu X, Hu W, Shen H, Chen J. Prevalence of hepatitis B virus and hepatitis C virus infection in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Oncotarget. 2017;8(60):102437–102445. PMID: 29254259; PMCID: PMC5731969. doi:10.18632/oncotarget.22261
   PubMedGoogle Scholar
• Fernandez-Ruiz R, Paredes JL, Niewold TB. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease. Transl Res. 2021;232:13–36. PMID: 33352298; PMCID: PMC7749645. doi:10.1016/j.trsl.2020.12.007
   PubMed Web of Science ®Google Scholar
• Kwan A, Rayes HA, Lazova T, et al. Herpes zoster in SLE: prevalence, incidence and risk factors. Lupus Sci Med. 2022;9(1):e000574. PMID: 35017186; PMCID: PMC8753438. doi:10.1136/lupus-2021-000574
   PubMed Web of Science ®Google Scholar
• Rondaan C, van Leer CC, Van assen S, et al. Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: no association with subclinical viral reactivations or lupus disease activity. Lupus. 2018;27(8):1271–1278. PMID: 29667858; PMCID: PMC6027773. doi:10.1177/0961203318770535
   PubMed Web of Science ®Google Scholar
• Bruminhent J, Autto S, Rotjanapan P, et al. A prospective study of cytomegalovirus-specific cell-mediated immune monitoring and cytomegalovirus infection in patients with active systemic lupus erythematosus receiving immunosuppressants. Open Forum Infect Dis. 2021;8(6):ofab248. PMID: 34189173; PMCID: PMC8231397. doi:10.1093/ofid/ofab248
   PubMed Web of Science ®Google Scholar
• Gugliesi F, Pasquero S, Griffante G, et al. Human cytomegalovirus and autoimmune diseases: where are we? Viruses. 2021;13(2):260. PMID: 33567734; PMCID: PMC7914970. doi:10.3390/v13020260
   PubMed Web of Science ®Google Scholar
• Méndez-Martínez S, García-Carrasco M, Jiménez-Herrera EA, et al. Factors of the epidemiological triad that influence the persistence of human papilloma virus infection in women with systemic lupus erythematosus. Lupus. 2018;27(9):1542–1546. PMID: 29732937. doi:10.1177/0961203318773176
   PubMed Web of Science ®Google Scholar
• Cacoub P, Comarmond C, Domont F, Savey L, Desbois AC, Saadoun D. Extrahepatic manifestations of chronic hepatitis C virus infection. Ther Adv Infect Dis. 2016;3(1):3–14. PMID: 26862398; PMCID: PMC4735500. doi:10.1177/2049936115585942
   PubMed Web of Science ®Google Scholar
• Illescas‐Montes R, Corona‐Castro CC, Melguizo‐Rodríguez L, Ruiz C, Costela‐Ruiz VJ. Infectious processes and systemic lupus erythematosus. Immunology. 2019;158(3):153–160.
   PubMed Web of Science ®Google Scholar
• James JA, Robertson JM. Lupus and epstein-barr. Curr Opin Rheumatol. 2012;24(4):383–388. PMID: 22504579; PMCID: PMC3562348. doi:10.1097/BOR.0b013e3283535801
   PubMed Web of Science ®Google Scholar
• Fu XL, Qian Y, Jin XH, et al. COVID-19 in patients with systemic lupus erythematosus: a systematic review. Lupus. 2022;31(6):684–696. PMID: 35382637; PMCID: PMC8990101. doi:10.1177/09612033221093502
   PubMed Web of Science ®Google Scholar
• Mehta P, Gasparyan AY, Zimba O, Kitas GD. Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management. Clin Rheumatol. 2022;41(9):2893–2910. PMID: 35639259; PMCID: PMC9152659. doi:10.1007/s10067-022-06227-7
   PubMed Web of Science ®Google Scholar
• Hsu CY, Ko CH, Wang JL, Hsu TC, Lin CY. Comparing the burdens of opportunistic infections among patients with systemic rheumatic diseases: a nationally representative cohort study. Arthritis Res Ther. 2019;21(1):211. PMID: 31604447; PMCID: PMC6790041. doi:10.1186/s13075-019-1997-5
   PubMed Web of Science ®Google Scholar
• Fang W, Chen M, Liu J, et al. Cryptococcal meningitis in systemic lupus erythematosus patients: pooled analysis and systematic review. Emerg Microbes Infect. 2016;5(9):e95. PMID: 27599471; PMCID: PMC5113055. doi:10.1038/emi.2016.93
   PubMedGoogle Scholar
• Su CF, Lai CC, Li TH, et al. Epidemiology and risk of invasive fungal infections in systemic lupus erythematosus: a nationwide population-based cohort study. Ther Adv Musculoskelet Dis. 2021;13:1759720X211058502. PMID: 34840609; PMCID: PMC8613894. doi:10.1177/1759720X211058502
   PubMed Web of Science ®Google Scholar
• Carli L, Tani C, Vagnani S, Signorini V, Mosca M. Leukopenia, lymphopenia, and neutropenia in systemic lupus erythematosus: prevalence and clinical impact--A systematic literature review. Semin Arthritis Rheum. 2015;45(2):190–194. PMID: 26170228. doi:10.1016/j.semarthrit.2015.05.009
   PubMed Web of Science ®Google Scholar
• Singh BK, Singh S. Systemic lupus erythematosus and infections. Reumatismo. 2020;72(3):154–169. PMID: 33213128. doi:10.4081/reumatismo.2020.1303
   PubMed Web of Science ®Google Scholar
• Almaghlouth I, Johnson SR, Pullenayegum E, Gladman D, Urowitz M. Immunoglobulin levels in systemic lupus erythematosus: a narrative review. Lupus. 2021;30(6):867–875. PMID: 33779380. doi:10.1177/09612033211004714
   PubMed Web of Science ®Google Scholar
• Yuan Q, Xing X, Lu Z, Li X. Clinical characteristics and risk factors of infection in patients with systemic lupus erythematosus: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum. 2020;50(5):1022–1039. PMID: 32911280. doi:10.1016/j.semarthrit.2020.06.004
   PubMed Web of Science ®Google Scholar
• Pimentel-Quiroz VR, Ugarte-Gil MF, Harvey GB, et al. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort. Lupus. 2019;28(9):1101–1110. PMID: 31291843. doi:10.1177/0961203319860579
   PubMed Web of Science ®Google Scholar
• Mok CC. Herpes zoster vaccination in systemic lupus erythematosus: the current status. Hum Vaccin Immunother. 2019;15(1):45–48. PMID: 30130445; PMCID: PMC6363132. doi:10.1080/21645515.2018.1514228
   PubMed Web of Science ®Google Scholar
• Prata AR, Luís M, Assunção H, da Silva JAP. Inês LS. Antimalarial treatment and minimizing prednisolone are associated with lower risk of infection in SLE: a 24-month prospective cohort study. Clin Rheumatol. 2022;41(4):1069–1078. PMID: 34782940. doi:10.1007/s10067-021-05988-x
   PubMed Web of Science ®Google Scholar
• Steiger S, Ehreiser L, Anders J, Anders HJ. Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials. Front Immunol. 2022;13:999704. PMID: 36211360; PMCID: PMC9538665. doi:10.3389/fimmu.2022.999704
   PubMed Web of Science ®Google Scholar
• Davis JS, Ferreira D, Paige E, Gedye C, Boyle M. Infectious complications of biological and small molecule targeted immunomodulatory therapies. Clin Microbiol Rev. 2020;33(3):e00035–19. PMID: 32522746; PMCID: PMC7289788. doi:10.1128/CMR.00035-19
   PubMed Web of Science ®Google Scholar
• Pan Q, Liu Z, Liao S, et al. Current mechanistic insights into the role of infection in systemic lupus erythematosus. Biomed Pharmacother. 2019;117:109122. doi:10.1016/j.biopha.2019.109122
   PubMed Web of Science ®Google Scholar
• Afrasiabi A, Keane JT, Ong LTC, et al. Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing systemic lupus erythematosus. J Autoimmun. 2022;127:102781. PMID: 34952359. doi:10.1016/j.jaut.2021.102781
   PubMed Web of Science ®Google Scholar
• Iwata S, Tanaka Y. Association of viral infection with the development and pathogenesis of systemic lupus erythematosus. Front Med. 2022;9:849120. PMID: 35280878; PMCID: PMC8914279. doi:10.3389/fmed.2022.849120
   Web of Science ®Google Scholar
• Rigante D, Mazzoni MB, Esposito S. The cryptic interplay between systemic lupus erythematosus and infections. Autoimmun Rev. 2014;13(2):96–102. PMID: 24051103. doi:10.1016/j.autrev.2013.09.004
   PubMed Web of Science ®Google Scholar
• Dizon BLP, Pierce SK. The tangled web of autoreactive B cells in malaria immunity and autoimmune disease. Trends Parasitol. 2022;38(5):379–389. PMID: 35120815; PMCID: PMC9012675. doi:10.1016/j.pt.2022.01.005
   PubMed Web of Science ®Google Scholar
• Sagy I, Zeller L, Raviv Y, Porges T, Bieber A, Abu-Shakra M. New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review. Rheumatol Int. 2022;42(12):2261–2266. PMID: 36098769; PMCID: PMC9468534. doi:10.1007/s00296-022-05203-3
   PubMed Web of Science ®Google Scholar
• He N, Leng X, Zeng X. Systemic lupus erythematosus following human papillomavirus vaccination: a case-based review. Int J Rheum Dis. 2022;25(10):1208–1212. PMID: 35948863. doi:10.1111/1756-185X.14404
   PubMed Web of Science ®Google Scholar
• Infante V, Miyaji KT, Soarez PC, Sartori AMC. Systematic review and meta-analysis of HPV vaccination in women with systemic lupus erythematosus (SLE). Expert Rev Vaccines. 2021;20(3):309–318. PMID: 33573404. doi:10.1080/14760584.2021.1889375
   PubMed Web of Science ®Google Scholar
• Fernandez D, Kirou KA. What causes lupus flares? Curr Rheumatol Rep. 2016;18(3):14. PMID: 26951252. doi:10.1007/s11926-016-0562-3
   PubMed Web of Science ®Google Scholar
• Joo YB, Lim YH, Kim KJ, Park KS, Park YJ. Association of influenza infection with hospitalisation-related systemic lupus erythematosus flares: a time series analysis. Clin Exp Rheumatol. 2021;39(5):1056–1062. PMID: 33124567. doi:10.55563/clinexprheumatol/fmkp4b
   PubMed Web of Science ®Google Scholar
• Ospina FE, Echeverri A, Zambrano D, et al. Distinguishing infections vs flares in patients with systemic lupus erythematosus. Rheumatology. 2017;56(suppl_1):i46–i54. PMID: 27744359. doi:10.1093/rheumatology/kew340
   PubMedGoogle Scholar
• Beça S, Rodríguez-Pintó I, Alba MA, Cervera R, Espinosa G. Development and validation of a risk calculator to differentiate flares from infections in systemic lupus erythematosus patients with fever. Autoimmun Rev. 2015;14(7):586–593. PMID: 25703012.s. doi:10.1016/j.autrev.2015.02.005
   PubMed Web of Science ®Google Scholar
• Singhal A, Kumar S. Neutrophil and remnant clearance in immunity and inflammation. Immunology. 2022;165(1):22–43. PMID: 34704249. doi:10.1111/imm.13423
   PubMed Web of Science ®Google Scholar
• Enocsson H, Gullstrand B, Eloranta ML, et al. C-reactive protein levels in systemic lupus erythematosus are modulated by the interferon gene signature and CRP gene polymorphism rs1205. Front Immunol. 2021;11:622326. PMID: 33584722; PMCID: PMC7876312. doi:10.3389/fimmu.2020.622326
   PubMed Web of Science ®Google Scholar
• El-Serougy E, Zayed HS, Ibrahim NM, Maged LA. Procalcitonin and C-reactive protein as markers of infection in systemic lupus erythematosus: the controversy continues. Lupus. 2019;28(11):1329–1336. PMID: 29779437. doi:10.1177/0961203318777101
   PubMed Web of Science ®Google Scholar
• He S, Tang C, Yu J, et al. Combining C reactive protein and serum albumin to predict 90-day mortality in systemic lupus erythematosus with serious community-acquired infections. Lupus Sci Med. 2021;8(1):e000505. PMID: 34253648; PMCID: PMC8276300. doi:10.1136/lupus-2021-000505
   PubMed Web of Science ®Google Scholar
• Chen Y, Shen J, Yang H, Xu S, Ma Y, Pan F. Serum procalcitonin and C-reactive protein levels as diagnostic markers for distinguishing bacterial infections from lupus flares in systemic lupus erythematosus: a systematic review and meta-analysis. Int Immunopharmacol. 2021;101(Pt B):108304. PMID: 34731783. doi:10.1016/j.intimp.2021.108304
   PubMedGoogle Scholar
• Yuan ZC, Xu WD, Lan YY, et al. Association of MBL2 gene polymorphisms and systemic lupus erythematosus susceptibility: a meta-analysis. Int J Rheum Dis. 2021;24(2):147–158. PMID: 33146461. doi:10.1111/1756-185X.14017
   PubMed Web of Science ®Google Scholar
• Feng M, Zhang SL, Liang ZJ, et al. Peripheral neutrophil CD64 index combined with complement, CRP, WBC count and B cells improves the ability of diagnosing bacterial infection in SLE. Lupus. 2019;28(3):304–316. PMID: 30712491. doi:10.1177/0961203319827646
   PubMed Web of Science ®Google Scholar
• Wang H. Regulation of HMGB1 release in health and diseases. Cells. 2022;12(1):46. PMID: 36611839; PMCID: PMC9818800. doi:10.3390/cells12010046
   PubMed Web of Science ®Google Scholar
• Ghosh A, Shao L, Sampath P, et al. Oligoadenylate-synthetase-family protein OASL inhibits activity of the DNA sensor cGAS during DNA virus infection to limit interferon production. Immunity. 2019;50(1):51–63.e5. PMID: 30635239; PMCID: PMC6342484. doi:10.1016/j.immuni.2018.12.013
   PubMed Web of Science ®Google Scholar
• Ajmani S, Singh H, Chaturvedi S, et al. Utility of neutrophil CD64 and serum TREM-1 in distinguishing bacterial infection from disease flare in SLE and ANCA-associated vasculitis. Clin Rheumatol. 2019;38(4):997–1005. PMID: 30446886. doi:10.1007/s10067-018-4334-5
   PubMed Web of Science ®Google Scholar
• Stefanski AL, Dörner T. Immune checkpoints and the multiple faces of B cells in systemic lupus erythematosus. Curr Opin Rheumatol. 2021;33(6):592–597. PMID: 34402453. doi:10.1097/BOR.0000000000000825
   PubMed Web of Science ®Google Scholar
• Hirohata S, Kikuchi H. Role of serum IL-6 in neuropsychiatric systemic lupus erythematosus. ACR Open Rheumatol. 2021;3(1):42–49. PMID: 33393227; PMCID: PMC7811696. doi:10.1002/acr2.11217
   PubMedGoogle Scholar
• Greenan-Barrett J, Doolan G, Shah D, et al. Biomarkers associated with organ-specific involvement in juvenile systemic lupus erythematosus. Int J Mol Sci. 2021;22(14):7619. PMID: 34299237; PMCID: PMC8306911. doi:10.3390/ijms22147619
   PubMed Web of Science ®Google Scholar
• Aragón CC, Ruiz-Ordoñez I, Quintana JH, et al. Clinical characterization, outcomes, and prognosis in patients with systemic lupus erythematosus admitted to the intensive care unit. Lupus. 2020;29(9):1133–1139. PMID: 32605526. doi:10.1177/0961203320935176
   PubMed Web of Science ®Google Scholar
• Mehta P, Singh K, Anand S, et al. Differentiating flare and infection in febrile lupus patients: derivation and validation of a calculator for resource constrained settings. Lupus. 2022;31(10):1254–1262. PMID: 35786213. doi:10.1177/09612033221112066
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Dahabreh IJ, Nihashi T, Iwata M, Varghese GM, Terasawa T. Nuclear imaging for classic fever of unknown origin: meta-analysis. J Nucl Med. 2016;57(12):1913–1919. PMID: 27339873. doi:10.2967/jnumed.116.174391
   PubMed Web of Science ®Google Scholar
• Bolouri N, Akhtari M, Farhadi E, et al. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus. Inflamm Res. 2022;71(5–6):537–554. PMID: 35298669. doi:10.1007/s00011-022-01554-6
   PubMed Web of Science ®Google Scholar
• Ugarte-Gil MF, González LA, Alarcón GS. Lupus: the new epidemic. Lupus. 2019;28(9):1031–1050. PMID: 31299878. doi:10.1177/0961203319860907
   PubMed Web of Science ®Google Scholar
• Mikdashi J, Nived O. Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research. Arthritis Res Ther. 2015;17(1):183. PMID: 26189728; PMCID: PMC4507322. doi:10.1186/s13075-015-0702-6
   PubMed Web of Science ®Google Scholar
• Thong KM, Chan TM. Infectious complications in lupus nephritis treatment: a systematic review and meta-analysis. Lupus. 2019;28(3):334–346. PMID: 30744523. doi:10.1177/0961203319829817
   PubMed Web of Science ®Google Scholar
• Zavala-Flores E, Salcedo-Matienzo J, Quiroz-Alva A, Berrocal-Kasay A. Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus. Clin Rheumatol. 2022;41(5):1349–1357. PMID: 34782941; PMCID: PMC8592807. doi:10.1007/s10067-021-05980-5
   PubMed Web of Science ®Google Scholar
• Aringer M, Alarcón-Riquelme ME, Clowse M, Pons-Estel GJ, Vital EM, Dall’Era M. A glimpse into the future of systemic lupus erythematosus. Ther Adv Musculoskelet Dis. 2022;14:1759720X221086719. PMID: 35368371; PMCID: PMC8972918. doi:10.1177/1759720X221086719
   PubMed Web of Science ®Google Scholar